NUA — System, Cystic Fibrosis Transmembrane Conductance Regulator, Gene Mutation Detection Class II

FDA Device Classification

Classification Details

Product Code
NUA
Device Class
Class II
Regulation Number
866.5900
Submission Type
Review Panel
PA
Medical Specialty
Immunology
Implant
No

Definition

The cftr gene mutation detection system is a device used to simultaneously detect and identify a panel of mutations and variants in the cftr gene. It is intended as an aid in confirmatory diagnostic testing of individuals with suspected cystic fibrosis (cf), carrier identification, and newborn screening. This device is not intended for stand-alone diagnostic purposes, prenatal diagnostic, pre-implantation or population screening.

Recent 510(k) Clearances

K-NumberApplicantDevice NameDate
K163347luminex molecular diagnosticsxTAG Cystic Fibrosis 39 Kit v2December 15, 2016
K163336luminex molecular diagnosticsxTAG Cystic Fibrosis 60 Kit v2, xTAG Data Analysis Software (TDAS) CFTRDecember 15, 2016
K083845luminex molecular diagnosticsXTAG CF60 KIT V2December 11, 2009
K083846luminex molecular diagnosticsXTAG CYSTIC FIBROSIS 39 KIT V2, (CFTR 39 KIT V2), MODEL I027C0231, I027D0266, I0September 1, 2009
K083294nanosphereVERIGENE CFTR NUCLEIC ACID TEST AND VERIGENE CFTR POLYT NUCLEIC ACID TESTJuly 24, 2009
K090901osmetech molecular diagnosticsESENSOR CF GENOTYPING TESTM ESENSOR SYSTEM, ESENSOR CYSTIC FIBROSIS GENOTYPING TJuly 6, 2009
K063787third wave technologiesINPLEX CF MOLECULAR TESTMarch 13, 2008
K062028celera diagnosticsCYSTIC FIBROSIS GENOTYPING ASSAY, MODEL 6L20-01September 7, 2007
K060627tm bioscience corporationTAG-IT CYSTIC FIBROSIS KITJune 7, 2006
K060543clinical micro sensorsESENSOR CYSTIC FIBROSIS CARRIER DETECTION SYSTEM, MODEL ESENSOR 4800March 28, 2006
K051435clinical micro sensorsESENSOR CYSTIC FIBROSIS CARRIER DETECTION TEST , ESENSOR 4800 DNA DETECTION SYSTJanuary 19, 2006
DEN050004tm bioscience corporationTAG-IT CYSTIC FIBROSIS KITMay 9, 2005